Loading...
See More

Wall St gains on data, rising oil prices

Jun 28 2012 07:55 Reuters

Related Articles

Wall St gives Facebook cautious nod

US stocks sink as crunch EU week begins

Wall St bounces back but Europe weighs

Wall St suffers worst loss in three weeks

Europe hits Wall St, Oracle rallies late

Wall St edges down in volatile trade

 

New York - US stocks rose on Wednesday as stronger-than-expected economic data helped lift energy stocks, overshadowing concerns a European Union summit will not yield tangible progress in easing the debt crisis.

The energy sector showed the strongest gains among the 10 major S&P 500 groups, rising 1.9% as oil prices settled higher at $80.21 a barrel. Cabot Oil & Gas Corp jumped 9% to $41.24 and was the biggest advancer on the S&P 500.

Worries about Europe have fed dramatic selloffs in stocks lately, but the declines have been tempered by enough short-term buying to keep the market confined to a range.

Sentiment was helped by better-than-expected sales of long-lasting US manufactured goods in May, although excluding transportation and defense items, orders were down.

In other data, signed contracts for home purchases jumped to a seven-month high. The PHLX housing sector index climbed 3%, taking the year-to-date gains near 26%.

Shares of Lennar Corp, the third-largest US homebuilder, rose 4.8% to $28.70 after it reported a rise in new orders for the fifth straight quarter.

"Sentiment is pretty negative. When you get people this depressed, markets have a tendency to bounce and that is pretty much where we are at right now," said Doug Foreman, director of equities at Kayne Anderson Rudnick Investment Management, an affiliated manager of Virtus Investment Partners in Los Angeles, California.

Arena Pharmaceuticals' surged 28.7% to $11.39 on news that US health regulators approved the drugmaker's pill to treat obesity, the first weight-loss drug in 13 years. The Nasdaq biotech index gained 1.5%.

But uncertainty remained ahead of the eurozone leaders' summit, which begins on Thursday. Few anticipate anything concrete to emerge from the two-day meeting after German Chancellor Angela Merkel said debt sharing, an idea backed by France, Italy and Spain, would not happen in her lifetime.

Healthcare stocks were in focus heading into Thursday's US Supreme Court decision on President Barack Obama's 2010 healthcare law. Some investors have their attention on stocks less likely to be affected by the ruling, such as large pharmaceuticals.

Many investors expect the requirement that uninsured Americans purchase health insurance to be overturned, "so people have had plenty of time to position their portfolios for that," said Foreman.

The Dow Jones industrial average gained 93.32 points, to 12,627.99. The Standard & Poor's 500 Index advanced 11.89 points, to 1,331.88. The Nasdaq Composite Index added 21.26 points, to 2,875.32.

The market's rise came on light volume of 5.75 billion billion shares traded on the New York Stock Exchange, NYSE Amex and Nasdaq.

The daily average year-to-date is 6.84 billion.

Shares of Vivus and Orexigen Therapeutics jumped following the FDA approval of Arena's obesity drug. The companies are also hoping to bring their medicines to market. Vivus shares were up 7.4% to $28.33 and Orexigen Therapeutics rose 20.3% to $4.92.

Some of Wall Street's top analysts published their research on Facebook, and most are cautiously optimistic. Facebook shares fell 2.6% to $32.32 after gaining more than 20% in the prior two weeks.

Advancing stocks outnumbered declining ones on the NYSE by 2,354 to 654, while on the Nasdaq, advancers beat decliners 1,766 to 706.

wall street  |  markets
NEXT ON FIN24X

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

We're talking about:

Small Business

New forms of digital technology are changing the very ways in which entrepreneurs run their businesses.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Loading...